<ѻýҕl>IBD Rates Low in Patients on Cosentyxѻýҕl> Analysis of data from 21 clinical trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis Jan 25, 2019
<ѻýҕl>Targeting IL-1 Fails in Knee OAѻýҕl> Little benefit seen for lutikizumab on scores for pain and function Jan 23, 2019
<ѻýҕl>Combo Biologics in RA? Be Cautiousѻýҕl> Risk of adverse events appeared to be less with tapered doses Dec 27, 2018
<ѻýҕl>Cancer Treatment and Arthritis: A Growing Complaintѻýҕl> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻýҕl>Infection Risk Lower With Orencia vs Anti-TNFѻýҕl> Increased risk for hospitalized infection with TNF inhibitors was driven largely by infliximab Dec 26, 2018
<ѻýҕl>Good News for Pregnant Women With Psoriatic Arthritisѻýҕl> No adverse effect on birth outcomes, and many reported fewer joint symptoms during pregnancy Dec 22, 2018
<ѻýҕl>IL-1 Blocker Fails for Hand Osteoarthritisѻýҕl> Pain, function, and structural changes were similar to placebo Dec 20, 2018
<ѻýҕl>ACR: Can Tanezumab Be Revived for OA?ѻýҕl> Low incidence of rapidly progressive OA seen with lower doses Oct 26, 2018
<ѻýҕl>In Psoriatic Arthritis, Doubling Down on IL-17ѻýҕl> Bimekizumab targets both IL-17A and F; "astonishing" results in psoriatic arthritis Oct 25, 2018
<ѻýҕl>RA Guideline Adherence Spotty, Study Findsѻýҕl> Treat-to-target recommendation not followed for half of patients Oct 23, 2018
<ѻýҕl>New JAK1 Agent Beats Humira in Rheumatoid Arthritisѻýҕl> Thrombotic events balanced between upadacitinib, adalimumab, and placebo Oct 22, 2018
<ѻýҕl>Understanding Neuropathic-Like Knee Painѻýҕl> Central risk factors may contribute to the condition, study shows Oct 13, 2018
<ѻýҕl>Nurses Can Lead the Way in Researchѻýҕl> ACR and EULAR studies demonstrated that research "is an important part of what we do" Aug 11, 2018
<ѻýҕl>Minimal Disease Activity: The Goal in PsAѻýҕl> Validity confirmed in large population of patients Jul 19, 2018
<ѻýҕl>CV Risk in RA: Questions Remainѻýҕl> TARGET study should fill in the clinical gaps Jul 16, 2018
<ѻýҕl>Enthesitis in PsA: A New Focus of Treatment?ѻýҕl> Targeting IL-23 with ustekinumab cleared enthesitis in three-quarters of patients Jun 22, 2018
<ѻýҕl>Can Diet Help in Psoriasis?ѻýҕl> Foundation's recommendations center on weight loss Jun 22, 2018
<ѻýҕl>Cardiovascular Risk in RA: Beyond Inflammation?ѻýҕl> With adverse lifestyle plus bad genes plus inflammation, 'you unleash hell' Jun 16, 2018
<ѻýҕl>Weight, Smoking Inhibit RA Remissionѻýҕl> Factors differ for women and men, but both relate to lifestyle Jun 15, 2018
<ѻýҕl>Meds Improve Cardiovascular Risk in RAѻýҕl> Benefits seen for hydroxychloroquine, methotrexate, and tocilizumab Jun 15, 2018
<ѻýҕl>Inflammatory Eye Disease: Complex, Scaryѻýҕl> Often related to autoimmune, inflammatory diseases May 10, 2018
<ѻýҕl>RA Therapy: After Methotrexate, Then What?ѻýҕl> Strong preference for anti-TNF therapy despite emerging data May 09, 2018
<ѻýҕl>Tocilizumab Beats Anti-TNFs for Treatment Retentionѻýҕl> Longer time on treatment, regardless of additional DMARDs May 08, 2018
<ѻýҕl>RA Patients Pose Perioperative Challengesѻýҕl> Expert discusses risk evaluation, stopping antirheumatic drugs May 07, 2018
<ѻýҕl>Biosimilar Switch Succeeds in Single Centerѻýҕl> Disease activity scores improved significantly after the change in rheumatoid arthritis patients May 04, 2018
<ѻýҕl>4-Year Data in PsA Reassuring for Apremilastѻýҕl> Benefits persist for joints and skin May 02, 2018
<ѻýҕl>Adalimumab Clears Nail Disease in Psoriatic Arthritisѻýҕl> Nail involvement often overlooked May 02, 2018
<ѻýҕl>Shocker! Is Vioxx Coming Back... as an Orphan Drug?ѻýҕl> Milton Packer wonders whether its return represents innovation or opportunism May 02, 2018
<ѻýҕl>Troponin Predicts Mortality in Inflammatory Arthritisѻýҕl> High levels associated with all-cause and cardiovascular death May 01, 2018
<ѻýҕl>FDA Panel Gives Celecoxib Positive CV Safety Gradeѻýҕl> Votes 15-5 that it is non-inferior to naproxen, ibuprofen Apr 25, 2018
<ѻýҕl>Respect the Needle in OAѻýҕl> Patients may be experiencing placebo effect, but it's still an effect, rheumatologist says Apr 19, 2018
<ѻýҕl>Young Arthritis Patients Fare Worse on MTXѻýҕl> High disease activity also linked with drug failure Mar 23, 2018
<ѻýҕl>Novel Tx Eases Osteoarthritic Knee Painѻýҕl> Geniculate artery embolization promising for knee pain, stiffness Mar 18, 2018
<ѻýҕl>Death Strikes Young in RAѻýҕl> Most common causes were circulatory, respiratory, and malignancy Mar 07, 2018
<ѻýҕl>One Gout Medication Comes Out on Top for CV Riskѻýҕl> Allopurinol the loser in retrospective comparison of two drugs Feb 26, 2018
<ѻýҕl>Cancer Risk Stable in Kids on Anti-TNFsѻýҕl> But background risks higher than in the general population Feb 20, 2018
<ѻýҕl>Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trialѻýҕl> Risankizumab broadly effective against joint and skin symptoms Nov 09, 2017
<ѻýҕl>ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologicsѻýҕl> Selections from late-breaker poster presentations at rheumatology meeting Nov 08, 2017
<ѻýҕl>Biologics During Pregnancy Don't Raise Infection Risk for Infantsѻýҕl> Gestational timing of exposure to biologic not an issue Nov 07, 2017
<ѻýҕl>Lipid Changes with Sirukumab Called 'Anti-Atherogenic'ѻýҕl> Looking for silver-lining in cloudy trial data Nov 06, 2017